Literature DB >> 1800034

Preliminary observation of continuous albendazole therapy in alveolar echinococcosis.

Y H Liu1, X G Wang, Y T Chen.   

Abstract

Fifteen cases of alveolar hydatid disease were treated with albendazole in the dosage of 20 mg/kg/d x 30 days for 12-60 courses. All cases were followed up 1-5 years (average 38 months) by ultrasonic scanning of liver and chest X-ray films. One patient whose hepatic lesion was converted into fibro-calcific after treatment was apparently cured. Twelve patients were symptomatically improved: jaundice (4 cases) and hemoptysis (2 cases) disappeared, with reduction in size of lesions in the liver and lung. Two patients in the late stage of disease with huge and extensive nodular masses in both lobes of the liver were not improved. Evidently, albendazole is effective in the treatment of alveolar hydatid disease. Early diagnosis and early treatment are to be emphasized.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1800034

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  2 in total

1.  Surgical treatment of advanced alveolar hydatid disease of the liver: a report of five cases.

Authors:  U Bengisun; G Tunç; M Kesenci; I Kuzu; S Demirci; B Aliç
Journal:  Surg Today       Date:  1997       Impact factor: 2.549

2.  Synthesis 1-acyl-3-(2'-aminophenyl) thioureas as anti-intestinal nematode prodrugs.

Authors:  Li-Ping Duan; Jia Xue; Li-Li Xu; Hao-Bing Zhang
Journal:  Molecules       Date:  2010-10-08       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.